Review: Heterogeneity of cytochrome P450 and its toxicological significance

Human & Experimental Toxicology

Volumn 14, Issue 1, 1995, Pages 1-7

  Paine, Alan J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cytochromes P450; species differences; toxicity; xenobiotic metabolism

Indexed keywords

CYTOCHROME P450;

ANIMAL EXPERIMENT; ENZYME INDUCTION; ENZYME SYNTHESIS; GENETIC HETEROGENEITY; HUMAN; LUNG CANCER; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT; SPECIES DIFFERENCE; TOXICOLOGY;

ANIMAL; CARCINOGENS, ENVIRONMENTAL; CYTOCHROME P-450 ENZYME SYSTEM; GENES; GENOTYPE; HUMAN; LUNG NEOPLASMS; MUTATION; RATS; RISK FACTORS;

EID: 0028854428     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/096032719501400101     Document Type: Review

References (25)

1. Paine A.J. Design of Toxicological Studies in General and Applied Toxicology, Ballantyne B, Marrs T & Turner P (eds) pp. 231-44. Macmillan-Stockton Press Ltd, Basingstoke, Hants, UK. 1993.
2. Remmer H. & Merker H.J. Effect of drugs on the formation of smooth endoplasmic reticulum and drug metabolising enzymes Annals New York Academy of Sciences 1965; 123: 79-97.
3. Michel H.O. Bernheim F. & Bernheim Hlc. Hydrolysis of acetanilide by various tissues Journal of Pharmacology and Experimental Therapeutics 1937; 61: 321-327.
4. Omura T. & Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature Journal of Biological Chemistry 1964; 239: 2370-2378.
5. Orrenius S.S. & Ernster L. Phenobarbital induced synthesis of the oxidative demethylating enzymes of rat liver microsomes. Biochemical and Biophysical Research Communications 1964; 16: 60-65.
6. Guengerich F.P. Enzymology of rat liver cytochromes P450 In Mammalian Cytochromes p450 Volume 1, Guengench F.P. (ed) pp. 1-54 CRC Press Inc, Boca Raton, Florida, 1987.
7. Lu Ayh & Kuntzman R. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds and endogenous substrates. I. Determination of substrate specificity by the cytochrome P450 and P448 fractions Biochemical and Biophysical Research Communication 1971; 42: 1200-1206.
8. Conney A.H. Pharmacological implications of microsomal enzyme induction Pharmacological Reviews 1967; 19: 317-366.
9. Yuan P.M. Ryan D.E. Levin W. & Shrively J.E. Identification and localisation of amino acid substitutions between two phenobarbital inducible rat hepatic microsomal cytochromes P450 by microsequence analysis Proceedings of the National Academy of Sciences USA 1983; 80: 1169-1173.
10. Nelson D.R. Kamataki T., Waxman D.J. Guengerich F.P. Estabrook R.W. Feyereisen R., Gonzalez F.J. Coon M.J. Gunsalus I.C. Gotoh O., Okuda K. & Nebert D.W. The P450 Superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature DNA and Cell Biology 1993; 12: 1-51.
11. Paine A.J. The Cytochrome P450 gene superfamily International Journal of Experimental Pathology 1991; 72: 349-363.
12. Janeczko R., Waxman D.J. Le Blanc G.A. Morville A. & Adesnik M. Hormonal regulation of levels of the messenger RNA encoding hepatic P450 2c (11C11), a constitutive male specific form of cytochrome P450 Molecular Endocrinology 1990; 4: 295-303.
13. Stevens J.C. & Wrighton S.A. The human hepatic cytochromes P450 involved in drug metabolism Critical Reviews in Toxicology 1992; 22: 1-21.
14. Lindberg Rlp & Negishi M. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino acid residue Nature 1989; 339: 632-634.
15. Gough A.C. Miles J.S. Spurr N.W. Moss J.E. Gaedigk A., Eichelbaum M. & Wolf C.R. Identification of the primary gene defect at the cytochrome P450 CYP2D locus Nature 1990; 347: 773-776.
16. Ayesh R., Idle J.R. Ritchie J.C. Crothers M.J. & Hetzel M.R. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer Nature 1984; 312: 169-170.
17. Barbeau A., Roy M., Paris S., Cloutier T., Plasse L. & Poirer J. The ecogenetics of Parkinson's disease: 4 hydroxylation of debrisoquine Lancet 1985; 2: 1213-1216.
18. Gelbion H.V. Weibel F.J. & Knoshita N. Microsomal aryl hydrocarbon hydroxylases: on their role in polycyclic hydrocarbon carcinogenesis and toxicity and the mechanism of enzyme induction In Biological Hydroxylation Mechanisms. Boyd G.S. & Smellie RMS (eds) pp. 103-33 Academic Press, London, 1972.
19. Geilen J.E. Goujon F.M. & Nebert D.W. Genetic regulation of Aryl Hydrocarbon Hydroxylase induction I.I. Simple mendelian expression in mouse tissues in vivo. Journal of Biological Chemistry 1972; 247: 1125-1137.
20. Kellerman G., Shaw C.R. & Luyten-Kehlerman M. Aryl Hydrocarbon Hydroxylase inducibility and bronchogenic carcinoma New England Journal of Medicine 1973; 289: 934-937.
21. Nakachi K., Imai K., Hayashi S. & Kawajiri K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population. Cancer Research 1993; 53: 2994-2999.
22. Vineis P., Bartsch H., Caporaso N., Harrington A.M. Kadlubar F.F. Landi M.T. Malaveille C., Sheilds P.G. Skipper P., Talaska G. & Tannenbaum S.R. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens Nature 1994; 369: 154-156.
23. Halpert J.R. Guengerich F.P. & Bend J.R. Correia M.A. Selective inhibitors of cytochromes P450 Toxicology and Applied Pharmacology 1994; 124: 163-175.
24. Kawajiri K., Watanabe J. & Hayashi S. Genetic polymorphism of P450 and human cancer In Cytochrome P450: Biochemistry Biophysics and Molecular Biology. Lechner M.C. (ed) pp. 155-162 John Libbey Eurotext, Paris, France.
25. Hakkola J., Markku P., Purknen R., Saarikoski S., Pelkonen O., Maenpaa J., Rane A. & Raunio H. Expression of Xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver Biochemical Pharmacology 1994; 48: 59-64.